Real-time enrollment status for this pulmonary arterial hypertension (pah) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:44 PM UTC
| NCT Number | NCT07175038 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Arterial Hypertension (PAH) |
| Phase | PHASE2 |
| Target Enrollment | 40 participants |
| Active Locations | 11 sites in the US |
| Sponsor | AllRock Bio, Inc. |
| Last Updated on CT.gov | October 8, 2026 (4 days ago) |
As of October 12, 2026: Clinical trial NCT07175038 is currently recruiting participants. This phase2 study for pulmonary arterial hypertension (pah) is actively seeking new participants at 11 locations across the United States. The study is sponsored by AllRock Bio, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07175038 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07175038 was last updated 4 days ago (October 8, 2026). HelloStudys verifies this status automatically.